ID: ALA355959

Max Phase: Preclinical

Molecular Formula: C15H23N3O10

Molecular Weight: 405.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC[C@H]1O[C@@H](OC(CO)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C15H23N3O10/c16-3-5-8(21)11(24)14(26-5)27-6(4-19)12-9(22)10(23)13(28-12)18-2-1-7(20)17-15(18)25/h1-2,5-6,8-14,19,21-24H,3-4,16H2,(H,17,20,25)/t5-,6?,8-,9+,10-,11-,12-,13-,14+/m1/s1

Standard InChI Key:  CSZXHEFWJRKHDV-ISCGUFRQSA-N

Associated Targets(non-human)

Phospho-N-acetylmuramoyl-pentapeptide-transferase 152 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 405.36Molecular Weight (Monoisotopic): 405.1383AlogP: -5.06#Rotatable Bonds: 6
Polar Surface Area: 209.72Molecular Species: BASEHBA: 12HBD: 7
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 8#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.70CX Basic pKa: 8.75CX LogP: -4.58CX LogD: -5.70
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.24Np Likeness Score: 1.53

References

1. Dini C, Drochon N, Feteanu S, Guillot JC, Peixoto C, Aszodi J..  (2001)  Synthesis of analogues of the O-beta-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 1: contribution of the amino group and the uracil moiety upon the inhibition of MraY.,  11  (4): [PMID:11229763] [10.1016/s0960-894x(00)00715-0]

Source